Kodak is involved in the release of drug components in the United States
Kodak's capabilities will be used to produce non-firm drug components in the United States. This was announced on July 28 by US President Donald Trump at a briefing in the White House. My administration has reached a historic agreement with a great American company. You remember her from the good old days of film photography. This is Kodak, said the American leader. Washington expects the company to be able to return to the United States the production of 25% of generic medicines that are now imported from abroad. Non-firm drugs can be as effective as branded drugs, but they cost much less, Trump explained. He added that to implement the planned plans, Kodak will receive a loan of $765 million. Thus, according to the American leader, a company that has lost its position will be able to provide the United States with sought-after pharmaceutical products.
Комментарии
Отправить комментарий